Capricor Therapeutics Gets Type-B Meeting With FDA for CAP-1

By Chris Wack


Capricor Therapeutics said Wednesday that it has an upcoming Type-B clinical meeting with the U.S. Food and Drug Administration planned for early in the third quarter.

During... | June 7, 2023

Related Keywords

Chris Wack , Drug Administration , Biologics License Application , Orphan Drug , Priority Review Voucher , Dow Jones , Capricor Therapeutics , Nc Stock Exchange , News , Information , Press Release , Y , Chris , Back , Capricor , Herapeutics , Aid , Wednesday , Hat , It , Gas , N , Pcoming , Linical , Meeting , Ith , The , Wood , End , Drug , Administration , Planned , Or , Early , Hird Capr Us14070b3096 ,